About 3D Plasty
3D Plastyspecialises in the production of 3D printed bioresorbable implants that are used in conjunction with surgical procedures to assist with the natural stages of bone healing. Osteopore's products are manufactured in-house using 3D printing technology that is precise and allows for customisation of shape and geometry.
The unique 3D printed biomimetic micro architecture of the 3D scaffolding which is contained within the 3D Plastyproducts provides for infiltration of cells and blood vessels, both of which play key roles in wound healing and tissue repair. 3D Plastyproducts are made of a US FDA approved polymer called polycaprolactone (PCL). PCL is bioresorbable, malleable, slow-degrading and possesses mechanical strength similar to trabecular bone.
Osteopore is involved in designing, developing and marketing bioresorbable polymer implants for neurosurgical, orthopaedic, and maxillofacial surgery use.
Osteopore's proprietary technologies allow for the development of biostructures which are synthetic biologically active tissue engineered products for the restoration of the human skeleton. Osteopore's core technology, the 3D printed biomimetic micro architecture which facilitates the bone healing process, provides multiple opportunities for growth through developing surgical implants and for pursuing regulatory approval for its products to initiate revenue opportunities.
3D printed biomimetic micro architecture is used in all of Osteopore's products.
Call To Action
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.Call To Action